Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multicenter, Non-interventional, Prospective, Longitudinal Study to Investigate the Effectiveness of Botulinum Toxin A (Dysport®) Injections in Patients Suffering From Post-stroke Arm Spasticity With Respect to Early, Medium or Late Start of Treatment.

NCT01840475 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01840475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01840475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multicenter, Non-interventional, Prospective, Longitudinal Study to Investigate the Effectiveness of Botulinum Toxin A (Dysport®) Injections in Patients Suffering From Post-stroke Arm Spasticity With Respect to Early, Medium or Late Start of Treatment.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
February 6, 2018
Enrollment
302 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

post-stroke arm spasticity